C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 20.5 NOK 2.5% Market Closed
Market Cap: 1.5B NOK
Have any thoughts about
Carasent ASA?
Write Note

Carasent ASA
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Carasent ASA
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
C
Carasent ASA
OSE:CARA
Operating Expenses
-kr242.6m
CAGR 3-Years
-49%
CAGR 5-Years
-50%
CAGR 10-Years
-4%
N
Nordhealth AS
OSE:NORDH
Operating Expenses
-€43m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Omda AS
OSE:OMDA
Operating Expenses
-kr252.7m
CAGR 3-Years
-11%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
No Stocks Found

Carasent ASA
Glance View

Market Cap
1.5B NOK
Industry
Health Care

Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. The company is headquartered in Oslo, Oslo. The company went IPO on 2002-04-08. The company operates through its subsidiary Evimeria EMR AB, which offers digital eHealth services primarily at specialist care, primary care and paramedics. The firm provides Webdoc, a Web-based care management system for health professionals that reduces the risk of resource-intensive routines. The system is customizable and also offers integration solutions. The firm is active in the Nordic region.

CARA Intrinsic Value
19.95 NOK
Overvaluation 3%
Intrinsic Value
Price
C

See Also

What is Carasent ASA's Operating Expenses?
Operating Expenses
-242.6m NOK

Based on the financial report for Jun 30, 2024, Carasent ASA's Operating Expenses amounts to -242.6m NOK.

What is Carasent ASA's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-4%

Over the last year, the Operating Expenses growth was -14%. The average annual Operating Expenses growth rates for Carasent ASA have been -49% over the past three years , -50% over the past five years , and -4% over the past ten years .

Back to Top